VICARIOUS SURGICAL INC-A (RBOT) Stock Fundamental Analysis

NYSE:RBOT • US92561V2088

1.92 USD
-0.12 (-5.88%)
At close: Mar 2, 2026
1.98 USD
+0.06 (+3.13%)
After Hours: 3/2/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall RBOT gets a fundamental rating of 2 out of 10. We evaluated RBOT against 184 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for RBOT as it has an excellent financial health rating, but there are worries on the profitability. RBOT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • RBOT had negative earnings in the past year.
  • RBOT had a negative operating cash flow in the past year.
  • In the past 5 years RBOT reported 4 times negative net income.
  • In the past 5 years RBOT always reported negative operating cash flow.
RBOT Yearly Net Income VS EBIT VS OCF VS FCFRBOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

  • RBOT's Return On Assets of -182.62% is on the low side compared to the rest of the industry. RBOT is outperformed by 89.13% of its industry peers.
  • RBOT's Return On Equity of -380.42% is on the low side compared to the rest of the industry. RBOT is outperformed by 79.35% of its industry peers.
Industry RankSector Rank
ROA -182.62%
ROE -380.42%
ROIC N/A
ROA(3y)-49.66%
ROA(5y)-48.14%
ROE(3y)-67.76%
ROE(5y)-64.37%
ROIC(3y)N/A
ROIC(5y)N/A
RBOT Yearly ROA, ROE, ROICRBOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

  • With a Gross Margin value of 5.76%, RBOT is not doing good in the industry: 81.52% of the companies in the same industry are doing better.
  • The Profit Margin and Operating Margin are not available for RBOT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RBOT Yearly Profit, Operating, Gross MarginsRBOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • RBOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • RBOT has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for RBOT has been reduced compared to 5 years ago.
  • There is no outstanding debt for RBOT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RBOT Yearly Shares OutstandingRBOT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
RBOT Yearly Total Debt VS Total AssetsRBOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • RBOT has an Altman-Z score of -15.74. This is a bad value and indicates that RBOT is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -15.74, RBOT is doing worse than 85.87% of the companies in the same industry.
  • RBOT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -15.74
ROIC/WACCN/A
WACC10.02%
RBOT Yearly LT Debt VS Equity VS FCFRBOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

  • A Current Ratio of 4.75 indicates that RBOT has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 4.75, RBOT is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
  • A Quick Ratio of 4.75 indicates that RBOT has no problem at all paying its short term obligations.
  • RBOT's Quick ratio of 4.75 is amongst the best of the industry. RBOT outperforms 80.43% of its industry peers.
Industry RankSector Rank
Current Ratio 4.75
Quick Ratio 4.75
RBOT Yearly Current Assets VS Current LiabilitesRBOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 12.05% over the past year.
  • The Revenue has grown by 160.31% in the past year. This is a very strong growth!
EPS 1Y (TTM)12.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.86%
Revenue 1Y (TTM)160.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, RBOT will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.05% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y23.95%
EPS Next 2Y27.18%
EPS Next 3Y19.05%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RBOT Yearly Revenue VS EstimatesRBOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2027 2028 2029 2030 20M 40M 60M 80M 100M
RBOT Yearly EPS VS EstimatesRBOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • RBOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year RBOT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBOT Price Earnings VS Forward Price EarningsRBOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RBOT Per share dataRBOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as RBOT's earnings are expected to grow with 19.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.18%
EPS Next 3Y19.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for RBOT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VICARIOUS SURGICAL INC-A

NYSE:RBOT (3/2/2026, 8:04:00 PM)

After market: 1.98 +0.06 (+3.13%)

1.92

-0.12 (-5.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)03-16
Inst Owners25.93%
Inst Owner Change29.3%
Ins Owners1.92%
Ins Owner Change-0.01%
Market Cap13.67M
Revenue(TTM)21.69M
Net Income(TTM)-53.59M
Analysts43.33
Price Target5.1 (165.63%)
Short Float %7.27%
Short Ratio3.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.03%
Min EPS beat(2)12.43%
Max EPS beat(2)21.62%
EPS beat(4)3
Avg EPS beat(4)11.32%
Min EPS beat(4)-2.78%
Max EPS beat(4)21.62%
EPS beat(8)5
Avg EPS beat(8)11.53%
EPS beat(12)8
Avg EPS beat(12)11.45%
EPS beat(16)9
Avg EPS beat(16)9.44%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-44.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.61%
EPS NY rev (1m)0%
EPS NY rev (3m)6.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.63
P/FCF N/A
P/OCF N/A
P/B 0.97
P/tB 0.97
EV/EBITDA N/A
EPS(TTM)-9.05
EYN/A
EPS(NY)-4.15
Fwd EYN/A
FCF(TTM)-6.72
FCFYN/A
OCF(TTM)-6.68
OCFYN/A
SpS3.05
BVpS1.98
TBVpS1.98
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -182.62%
ROE -380.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.76%
FCFM N/A
ROA(3y)-49.66%
ROA(5y)-48.14%
ROE(3y)-67.76%
ROE(5y)-64.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.75
Quick Ratio 4.75
Altman-Z -15.74
F-Score3
WACC10.02%
ROIC/WACCN/A
Cap/Depr(3y)193.53%
Cap/Depr(5y)211.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.86%
EPS Next Y23.95%
EPS Next 2Y27.18%
EPS Next 3Y19.05%
EPS Next 5YN/A
Revenue 1Y (TTM)160.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year51.85%
EBIT Next 3Y23.49%
EBIT Next 5YN/A
FCF growth 1Y32.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.43%
OCF growth 3YN/A
OCF growth 5YN/A

VICARIOUS SURGICAL INC-A / RBOT FAQ

What is the ChartMill fundamental rating of VICARIOUS SURGICAL INC-A (RBOT) stock?

ChartMill assigns a fundamental rating of 2 / 10 to RBOT.


What is the valuation status of VICARIOUS SURGICAL INC-A (RBOT) stock?

ChartMill assigns a valuation rating of 0 / 10 to VICARIOUS SURGICAL INC-A (RBOT). This can be considered as Overvalued.


What is the profitability of RBOT stock?

VICARIOUS SURGICAL INC-A (RBOT) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for RBOT stock?

The Earnings per Share (EPS) of VICARIOUS SURGICAL INC-A (RBOT) is expected to grow by 23.95% in the next year.